DIA and MHRA Initiate Groundbreaking Global Summit to Enhance Health Innovation and Patient Safety

Advancing Health Innovation: The DIA-MHRA Global Summit

On November 16-17, 2026, a significant event is set to unfold in London as the Drug Information Association (DIA) collaborates with the Medicines and Healthcare products Regulatory Agency (MHRA) to host the DIA-MHRA Global Summit. This summit, themed "Global Collaboration for Safer and Smarter Health Innovation," aims to gather prominent leaders across the life sciences spectrum to enhance collaboration, drive innovation, and improve patient access to healthcare.

Why This Summit Matters

The context of the summit arises from a world increasingly challenged by a complex health landscape. Innovations such as digital health technologies, advanced therapeutic modalities, and the growing role of artificial intelligence have transformed patient care. However, the need for effective regulation and safety measures has never been more crucial. The DIA-MHRA Global Summit aims to address these pressing issues head-on, establishing a platform for knowledge exchange and cooperative engagement among regulators, industry leaders, researchers, and patient advocates.

Key Commitments of the Summit

The summit is founded on three essential commitments:

1. Patient Safety and Public Health Impact: Pushing for strong regulatory frameworks that prioritize patient safety while supporting comprehensive pharmacovigilance across global markets.

2. Scientific Innovation and Regulatory Modernization: Encouraging adaptive, evidence-based approaches to drug development that can keep pace with emerging therapies and practices in the healthcare sector.

3. Global Collaboration and Knowledge Exchange: Building an interconnected health innovation ecosystem through consistent dialogue among regulators, industry professionals, healthcare providers, and patient advocates.

By uniting the international legislative authority of MHRA with the global reach of DIA, the summit promises to be a productive gathering where experts can discuss significant challenges and opportunities in regulatory science.

Engaging Programs and Discussions

The two-day agenda includes keynote speeches, panel discussions, and case studies focused on groundbreaking topics such as next-gen medicines, including cell and gene therapies, mRNA applications in healthcare, and the future of clinical research. Participants can expect to delve into real-world evidence, the impact of AI in healthcare, and strategies for global regulatory alignment. There will also be a focus on biomedical investments, innovative healthcare strategies, and methods to improve patient access, especially for those suffering from rare diseases.

Voices from Leadership

Marwan Fathallah, CEO of DIA, emphasizes the significance of collaboration, stating: “The DIA-MHRA Global Summit will create a space where regulators, industry, academia, and patient advocates can engage openly, share knowledge, and move health innovation forward together.” Meanwhile, Lawrence Tallon, CEO of MHRA, adds: “Innovation is most powerful when driven by collaboration… This unique forum for global dialogue will accelerate innovation and strengthen public trust, ultimately delivering better patient outcomes.”

The Program Committee

To steer the vision and scientific agenda for the summit, a Program Committee composed of experts from regulatory affairs and health innovation will oversee the event. The committee features distinguished members, including Virginia Acha of Merck and Julian Beach from MHRA, among others, who will help shape the strategic direction and ensure that the summit addresses the most pressing issues facing the global health community.

Ultimately, the DIA-MHRA Global Summit stands as a pivotal moment for better healthcare delivery, collaboration, and innovation in a rapidly evolving industry. By gathering key stakeholders from various sectors, the summit is poised to generate solutions and partnerships that will influence the future of healthcare at a global scale.

For more information about the summit, visit DIA's website.